Dahl Andrew M. reported tax withholding involving 101 shares of Edwards Lifesciences Corp at $105.80 for −$10.7k on Nov 13, 2026

Tax withholding
Form 4 code F. Payment of an exercise price or tax liability by delivering or withholding securities in a Rule 16b-3 transaction.
SVP, Corporate Controller
SVP, Corporate Controller
Filed Nov 13, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$10,685.80Shares × reported price
Shares traded
101Common Stock
Price per share
$105.80Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
14,605.7777Direct
Trade date
Nov 13, 2026Tax withholding
Filed
Nov 13, 2026, 8:21 PM ET1-day reporting delay
Accession
0001225208-26-009012Code F · Transaction 401499
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

EW price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
EW · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 21, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −19%1w ago −4.7%1d ago −1.3%
Returns since7d30d90d180d1y

Footnotes in full

F1: Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e).